SELLAS Life Sciences (SLS) Assets Average (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Assets Average for 9 consecutive years, with $20.8 million as the latest value for Q3 2024.
- Quarterly Assets Average rose 56.18% to $20.8 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $20.8 million through Sep 2024, up 56.18% year-over-year, with the annual reading at $13.6 million for FY2023, 42.48% down from the prior year.
- Assets Average for Q3 2024 was $20.8 million at SELLAS Life Sciences, up from $19.8 million in the prior quarter.
- The five-year high for Assets Average was $43.3 million in Q1 2021, with the low at $7.2 million in Q4 2023.
- Average Assets Average over 5 years is $24.6 million, with a median of $23.8 million recorded in 2023.
- The sharpest move saw Assets Average skyrocketed 166.96% in 2021, then plummeted 69.53% in 2023.
- Over 5 years, Assets Average stood at $32.3 million in 2020, then fell by 0.51% to $32.1 million in 2021, then dropped by 26.91% to $23.5 million in 2022, then tumbled by 69.53% to $7.2 million in 2023, then skyrocketed by 190.98% to $20.8 million in 2024.
- According to Business Quant data, Assets Average over the past three periods came in at $20.8 million, $19.8 million, and $15.3 million for Q3 2024, Q2 2024, and Q1 2024 respectively.